Candida Utilis Market Size, Share, Growth, and Industry Analysis, By Type (Food Grade, Feed Grade), By Application (Food and Beverage Industry, Animal Feed and Pet Food, Pharmaceutical Industry, Others), and Regional Forecast to 2035

CANDIDA UTILIS MARKET REPORT OVERVIEW

The global Candida Utilis Market size estimated at USD 323.44 million in 2026 and is projected to reach USD 506.09 million by 2035, growing at a CAGR of 5.1% from 2026 to 2035.

The Candida utilis belongs to the category of those fungi that make up a rather large proportion of blood infections, especially in hospitals. This report provides a description of Candida utilis, how often this organisms is isolated, how it is identified and how it behaves with respect to therapy. It also explores the aspects of the market associated with this fungus – for example, the size of the market and who plays the market and who gains most from it. The aim is to inform anyone who is or is willing to be associated with the industry, whether as an investor or as a researcher with an intent to make better policies.

• • 

    Request a Free sample to learn more about this report.

KEY FINDINGS

• Market Size and Growth: The Candida Utilis Market size was USD 292.81 Million in 2024, is projected to grow to USD 308.74 Million by 2025 and exceed USD 458.16 Million by 2033, with a CAGR of 5.1%.

• Key Market Driver: Rising demand for sustainable protein sources is driving adoption, with yeast-based proteins showing up to 60% protein content in dry matter, making them a cost-effective alternative to animal proteins.

• Major Market Restraint: Limited awareness among food and feed manufacturers still slows wider adoption, with surveys indicating less than 35% of small-scale producers currently familiar with yeast-derived protein benefits.

• Emerging Trends: Growing use of Candida utilis in aquaculture feed is shaping the market, with aquaculture production crossing 90 million metric tons globally in 2023, creating new opportunities for sustainable feed alternatives.

• Regional Leadership: Europe leads the market, supported by strict sustainability regulations and high adoption of alternative proteins, with nearly 42% of plant- and yeast-based protein innovation patents originating from the region in recent years.

• Competitive Landscape: The market is moderately fragmented, with over 20 notable players actively investing in yeast biotechnology, and at least 8 companies expanding their R&D pipelines in microbial protein innovations during 2022–2023.

• Market Segmentation: Animal feed remains a dominant segment, accounting for close to 55% of overall applications, driven by the push to replace fishmeal and soy protein with more sustainable yeast-based alternatives.

• Recent Development: In 2023, several biomanufacturers announced partnerships to scale yeast fermentation capacity, with at least 3 facilities expanding production lines to increase output by over 25% compared to 2021 levels.

COVID-19 IMPACT

"Weakened immunity and poor hygiene fueled fungal growth"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The Candida utilis to overpopulate through the entire period of COVID-19. This fungus began to grow intensely when I wrote about the use of such drugs as dexamethasone in suppressing the immune system. COVID also broke hygiene standards and sanitation, and this increased fungal infections’ occurrence. Once again, during the virus outbreak Candida was isolated in sewage and this may apparently confirm its danger in initially affected zones.

LATEST TRENDS

"Advancements in identification boost demand for natural ingredients and medicines"

Recent trends in the Candida Utilis Market show improvements in identifying the fungus, rising interest in natural ingredients for food and drinks, and more use in animal feed. Research is also growing into its antifungal benefits, which is increasing its use in medicines. These developments are helping the market expand and find new uses in different industries.

• • 

    Request a Free sample to learn more about this report.

CANDIDA UTILIS MARKET SEGMENTATION

By Type:

• Food Grade: Used as a natural ingredient in food and beverages for its beneficial properties.

• Feed Grade: Utilized in animal feed and pet food to enhance nutritional content.

By Application:

• Food and Beverage Industry: Incorporated into products for its fermentation and flavoring capabilities.

• Animal Feed and Pet Food: Added to feed to improve health and growth of livestock and pets.

• Pharmaceutical Industry: Applied in the production of antifungal medications and health supplements.

• Others: Includes miscellaneous applications in various sectors like cosmetics and bioengineering.

DRIVING FACTORS

"Rising Fungal Infections Increase Demand for Effective Antifungal Treatments"

The higher rates of fungal infections in the global population make it necessary to obtain exquisite antifungal reagents derived from Candida utilis. As the occurrence of fungal infections rises and as the technology in delivering antifungal remedies advances, the providers of such remedies have to seek better solutions from Candida utilis making the market for Candida utilis products better. However, benefits vary across markets: especially in immunocompromised patients and antibiotic-resistant infections, new antifungal treatments are however lacking.

"Growing demand for natural ingredients drives increased use of Candida utilis"

Ulitis candida is slowly taking its place in the market especially in the food sector, feeds and in animal and drug sector. The specifics of its usage relate to food industry, animal feeding, preservation of food and its shelf life and as pharmaceutical ingredients to name but a few. The focus on the consumption of natural and functional components in these industries is quite favorable for Candida utilis which in turn is stimulating the market. The general utilisation of Value Added Yeast By Products in consumer products makes the general utilization of the Candida utilis in various fields more and more enhanced.

RESTRAINING FACTOR

"Strict rules and high costs limit growth and product development"

The Candida Utilis Market struggles with strict rules about using yeast in food and medicine, which can slow down its growth. High costs for research and development also pose a challenge. Moreover, some people may have allergic reactions, which can limit market opportunities. These issues make it harder for companies to expand and develop new products, affecting the market's overall potential.

• • 

    Request a Free sampleto learn more about this report.

•  

CANDIDA UTILIS MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America to Dominate the Market due to Technological Advancements"

The market is mainly divided into Europe, Latin America, Asia Pacific, North America, and the Middle East & Africa. North America is set to lead due to its advanced healthcare system and high demand for yeast products. Europe is next, thanks to its focus on new ideas and regulations. Asia-Pacific will grow the fastest because of its large population and increasing use of Candida utilis in various industries. Latin America and the Middle East & Africa will grow more slowly but still offer opportunities.

KEY INDUSTRY PLAYERS

"Leading Companies Innovate Yeast Products, Boosting Industry Growth"

Key companies in the Candida Utilis Market include Ohly (ABF), Lallemand, Lesaffre, Oriental Yeast, Sunkeen, Biorigin, TAISHO TECHNOS CO., LTD., and MP Biomedicals. These firms are leaders in the market, known for their innovations in yeast products and strategic business moves. They help drive the growth of the Candida Utilis Market by improving product offerings and expanding their reach.

LIST OF MARKET PLAYERS PROFILED

• Ohly (ABF) (Germany)
• Lallemand (Canada)
• Lesaffre (France)
• Oriental Yeast (Japan)
• Sunkeen (China)
• MP Biomedicals (U.S.)

INDUSTRIAL DEVELOPMENT

June 2024, Ohly (ABF) invested in new technology to boost Candida utilis production, making it more efficient and meeting rising demand. Lallemand also expanded its research facilities in July 2024 to enhance the antifungal benefits of Candida utilis. These moves show a strong focus on improving products and keeping up with market needs, highlighting the industry's growth and commitment to better solutions.

REPORT COVERAGE

The report provides a comprehensive analysis of the Candida Utilis Market, including insights into market dynamics, segmentation, competitive landscape, and regional trends. It offers detailed information on market drivers, restraints, and key industry players. This coverage helps stakeholders understand market opportunities, challenges, and strategic positions to make informed decisions.